Description of Leukocytes in Patients who are Positive for COVID-19 Infection

Authors

  • Marliana Nurprilinda Department of Pathology, Faculty of Medicine, Universitas Kristen, Jakarta, Indonesia
  • Erica Gilda Misnawati Simanjuntak Department of Anesthesiology, Faculty of Medicine, Universitas Kristen Indonesia

Abstract

In December 2019, the first mysterious pneumonia case was reported in Wuhan, Hubei Province. Based on the obtained information, the first case was associated with a fish market in Wuhan, and five cases were found with Acute Respiratory Distress Syndrome (ARDS). These cases continue to rise from December 31, 2019, to January 3, 2020, with 44 cases found. This research aims to know the description and the correlation between the levels of leukocytes and the value of the rRT-PCR COVID-19. This research uses descriptive design linear regression analysis, bivariate with a cross-sectional approach using patients' medical records. Researchers obtained 77 samples of patients who examined the rRT-PCR COVID-19 at one hospital in East Bekasi, West Java. The results of this study showed a significant correlation between the levels of leukocytes with the results of the examination of the rRT- PCR COVID-19 (P=0.01) and decreased levels of leukocytes at the beginning of the examination of the rRT-PCR (R= -2, 92).

Keywords: COVID-19, Leukocytes

Keywords:

COVID-19, Leukocytes, rRT-PCR

DOI

https://doi.org/10.22270/jddt.v13i11.6026

Author Biographies

Marliana Nurprilinda, Department of Pathology, Faculty of Medicine, Universitas Kristen, Jakarta, Indonesia

Department of Pathology, Faculty of Medicine, Universitas Kristen, Jakarta, Indonesia

Erica Gilda Misnawati Simanjuntak, Department of Anesthesiology, Faculty of Medicine, Universitas Kristen Indonesia

Department of Anesthesiology, Faculty of Medicine, Universitas Kristen Indonesia

References

Gabutti G, d'Anchera E, Sandri F, Savio M, Stefanati A. Coronavirus: update related to the current outbreak of COVID-19. Infectious diseases and therapy. 2020 Jun;9:241-53. https://doi.org/10.1007/s40121-020-00295-5 PMid:32292686 PMCid:PMC7139198

Cheng VC, Wong SC, Chen JH, Yip CC, Chuang VW, Tsang OT, Sridhar S, Chan JF, Ho PL, Yuen KY. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infection Control & Hospital Epidemiology. 2020 May;41(5):493-8. https://doi.org/10.1017/ice.2020.58 Mid:32131908 PMCid:PMC7137535

Acter T, Uddin N, Das J, Akhter A, Choudhury TR, Kim S. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency. Science of the Total Environment. 2020 Aug 15;730:138996. https://doi.org/10.1016/j.scitotenv.2020.138996 PMid:32371230 PMCid:PMC7190497

Asaduzzaman M, Shobnam A, Farukuzzaman MD, Gaffar A, Juliana FM, Sharker T, Dutta KK, Islam MJ. Assessment of Red Blood Cell Indices, White Blood Cells, Platelet Indices and Procalcitonin of Chronic Kidney Disease Patients under Hemodialysis. Int. J. Health Sci. Res. 2018;8:98-109.

Khajehali N, Alizadeh S. Extract critical factors affecting the length of hospital stay of pneumonia patient by data mining (case study: an Iranian hospital). Artificial intelligence in medicine. 2017 Nov 1;83:2-13. https://doi.org/10.1016/j.artmed.2017.06.010 PMid:28712673

Yang J, Zheng YA, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhou Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International journal of infectious diseases. 2020 May 1;94:91-5. https://doi.org/10.1016/j.ijid.2020.03.017 PMid:32173574 PMCid:PMC7194638

Kahar F, Dirawan GD, Samad S, Qomariyah N, Purlinda DE. The epidemiology of COVID-19, attitudes and behaviors of the community during the Covid pandemic in Indonesia. structure. 2020;10(8). https://doi.org/10.38124/IJISRT20AUG670

Kirana AP, Bhawiyuga A. Coronavirus (COVID-19) pandemic in Indonesia: cases overview and daily data time series using naïve forecast method. Indonesian Journal of electronics, electromedical engineering, and medical informatics. 2021 Feb 21;3(1):1-8. https://doi.org/10.35882/ijeeemi.v3i1.1

Serrano-Gemes G, Serrano-del-Rosal R, Rich-Ruiz M. Experiences in the decision-making regarding the place of care of the elderly: a systematic review. Behavioral Sciences. 2021 Jan 21;11(2):14. https://doi.org/10.3390/bs11020014 PMid:33494258 PMCid:PMC7921973

Traish AM, Morgentaler A. What's testosterone got to do with it? A critical assessment of the contribution of testosterone to gender disparities in COVID-19 infections and deaths. Androgens: Clinical Research and Therapeutics. 2021 Jan 1;2(1):18-35. https://doi.org/10.1089/andro.2020.0012

Shnawa IM. The COVID-19 vaccine race, vaccine immunity and vaccine herd immunity. Clin Med. 2020;5:1-4. https://doi.org/10.15761/CMI.1000205

Smits VA, Hernández-Carralero E, Paz-Cabrera MC, Cabrera E, Hernández-Reyes Y, Hernández-Fernaud JR, Gillespie DA, Salido E, Hernández-Porto M, Freire R. The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients. Biochemical and biophysical research communications. 2021 Mar 5;543:45-9. https://doi.org/10.1016/j.bbrc.2021.01.073 PMid:33515911 PMCid:PMC7825866

Pal M, Berhanu G, Desalegn C, Kandi V. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus. 2020 Mar 26;12(3). https://doi.org/10.7759/cureus.7423

Hasöksüz M, Kilic S, Saraç F. Coronaviruses and sars-cov-2. Turkish journal of medical sciences. 2020;50(9):549-56. https://doi.org/10.3906/sag-2004-127 PMid:32293832 PMCid:PMC7195990

Badraoui R, Alrashedi MM, El-May MV, Bardakci F. Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19. Journal of Biomolecular Structure and Dynamics. 2021 Nov 22;39(17):6842-51. https://doi.org/10.1080/07391102.2020.1803139 PMid:32752936 PMCid:PMC7484582

Anand KB, Karade S, Sen S, Gupta RM. SARS-CoV-2: camazotz's curse. medical journal armed forces india. 2020 Apr 1;76(2):136-41. https://doi.org/10.1016/j.mjafi.2020.04.008 PMid:32341622 PMCid:PMC7183968

Davidson AM, Wysocki J, Batlle D. Interaction of SARS-CoV-2 and other coronavirus with ACE (angiotensin-converting enzyme)-2 as their main receptor: therapeutic implications. Hypertension. 2020 Nov;76(5):1339-49. https://doi.org/10.1161/HYPERTENSIONAHA.120.15256 PMid:32851855 PMCid:PMC7480804

Duda-Chodak A, Lukasiewicz M, Zięć G, Florkiewicz A, Filipiak-Florkiewicz A. Covid-19 pandemic and food: Present knowledge, risks, consumers fears and safety. Trends in Food Science & Technology. 2020 Nov 1;105:145-60. https://doi.org/10.1016/j.tifs.2020.08.020 PMid:32921922 PMCid:PMC7480472

Delikhoon M, Guzman MI, Nabizadeh R, Norouzian Baghani A. Modes of transmission of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) and factors influencing on the airborne transmission: A review. International journal of environmental research and public health. 2021 Jan;18(2):395. https://doi.org/10.3390/ijerph18020395 PMid:33419142 PMCid:PMC7825517

Ranjan K. Environmental Persistence of SARS-CoV-2 and Disinfection of Work Surfaces in View of Pandemic Outbreak of COVID-19. Disinfection of Viruses. 2022 Apr 18. https://doi.org/10.5772/intechopen.104520

Ryu WS. Virus life cycle. Molecular virology of human pathogenic viruses. 2017:31. https://doi.org/10.1016/B978-0-12-800838-6.00003-5 PMCid:PMC7158286

Moradi-Kalbolandi S, Majidzadeh-A K, Abdolvahab MH, Jalili N, Farahmand L. The role of mucosal immunity and recombinant probiotics in SARS-CoV2 vaccine development. Probiotics and antimicrobial proteins. 2021 Oct 1:1-5. https://doi.org/10.1007/s12602-021-09773-9 PMid:33770348 PMCid:PMC7996120

Seyran M, Takayama K, Uversky VN, Lundstrom K, Palù G, Sherchan SP, Attrish D, Rezaei N, Aljabali AA, Ghosh S, Pizzol D. The structural basis of accelerated host cell entry by SARS‐CoV‐2. The FEBS journal. 2021 Sep;288(17):5010-20. https://doi.org/10.1111/febs.15651 PMid:33264497 PMCid:PMC7753708

Koch J, Uckeley ZM, Doldan P, Stanifer M, Boulant S, Lozach PY. TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells. The EMBO journal. 2021 Aug 16;40(16):e107821. https://doi.org/10.15252/embj.2021107821 PMid:34159616 PMCid:PMC8365257

Garcia-Blanco MA, Vasudevan SG, Bradrick SS, Nicchitta C. Flavivirus RNA transactions from viral entry to genome replication. Antiviral research. 2016 Oct 1;134:244-9. https://doi.org/10.1016/j.antiviral.2016.09.010 PMid:27666184

Rijkers GT, Weterings N, Obregon-Henao A, Lepolder M, Dutt TS, van Overveld FJ, Henao-Tamayo M. Antigen presentation of mRNA-based and virus-vectored SARS-CoV-2 vaccines. Vaccines. 2021 Aug 3;9(8):848. https://doi.org/10.3390/vaccines9080848 PMid:34451973 PMCid:PMC8402319

Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. Journal of pharmaceutical analysis. 2020 Apr 1;10(2):102-8. https://doi.org/10.1016/j.jpha.2020.03.001 PMid:32282863 PMCid:PMC7104082

Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodríguez L. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytokine & growth factor reviews. 2020 Aug 1;54:62-75. https://doi.org/10.1016/j.cytogfr.2020.06.001 PMid:32513566 PMCid:PMC7265853

Maurizi G, Della Guardia L, Maurizi A, Poloni A. Adipocytes properties and crosstalk with immune system in obesity‐related inflammation. Journal of cellular physiology. 2018 Jan;233(1):88-97. https://doi.org/10.1002/jcp.25855 PMid:28181253

Barochiner J, Martinez R. Use of inhibitors of the renin‐angiotensin system in hypertensive patients and COVID‐19 severity: a systematic review and meta‐analysis. Journal of Clinical Pharmacy and Therapeutics. 2020 Dec;45(6):1244-52. https://doi.org/10.1111/jcpt.13246 PMid:32767823 PMCid:PMC7436708

Zaki N, Mohamed EA. The estimations of the COVID-19 incubation period: A scoping reviews of the literature. Journal of infection and public health. 2021 May 1;14(5):638-46. https://doi.org/10.1016/j.jiph.2021.01.019 PMid:33848893 PMCid:PMC7869687

Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: An overview. Journal of the Chinese medical association. 2020 Mar;83(3):217. https://doi.org/10.1097/JCMA.0000000000000270 PMid:32134861 PMCid:PMC7153464

Younes N, Al-Sadeq DW, Al-Jighefee H, Younes S, Al-Jamal O, Daas HI, Yassine HM, Nasrallah GK. Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2. Viruses. 2020 May 26;12(6):582. https://doi.org/10.3390/v12060582 PMid:32466458 PMCid:PMC7354519

Ulas C, Ozgur I, Burcin C, Faruk S, Muharrem O. Clinical course of COVID-19 pneumonia in a patient undergoing pneumonectomy and pathology findings during the incubation period. Swiss Medical Weekly. 2020;150. https://doi.org/10.4414/smw.2020.20302 PMid:32580215

Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients. Ajr Am J Roentgenol. 2020 Jul 1;215(1):87-93. https://doi.org/10.2214/AJR.20.23034 PMid:32174129

Al-Dulaimi KA, Banks J, Chandran V, Tomeo-Reyes I, Nguyen Thanh K. Classification of white blood cell types from microscope images: Techniques and challenges. Microscopy science: Last approaches on educational programs and applied research (Microscopy Book Series, 8). 2018:17-25.

Terpos E, Ntanasis‐Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA. Hematological findings and complications of COVID‐19. American journal of hematology. 2020 Jul;95(7):834-47. https://doi.org/10.1002/ajh.25829 PMid:32282949 PMCid:PMC7262337

Younes N, Al-Sadeq DW, Al-Jighefee H, Younes S, Al-Jamal O, Daas HI, Yassine HM, Nasrallah GK. Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2. Viruses. 2020 May 26;12(6):582. https://doi.org/10.3390/v12060582 PMid:32466458 PMCid:PMC7354519

Zhao K, Li R, Wu X, Zhao Y, Wang T, Zheng Z, Zeng S, Ding X, Nie H. Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis. European Journal of Clinical Microbiology & Infectious Diseases. 2020 Dec;39:2279-87. https://doi.org/10.1007/s10096-020-03976-8 PMid:32651736 PMCid:PMC7351641

Published

15-11-2023
Statistics
Abstract Display: 152
PDF Downloads: 126
PDF Downloads: 130

How to Cite

1.
Nurprilinda M, Simanjuntak EGM. Description of Leukocytes in Patients who are Positive for COVID-19 Infection. J. Drug Delivery Ther. [Internet]. 2023 Nov. 15 [cited 2025 Feb. 13];13(11):127-35. Available from: https://jddtonline.info/index.php/jddt/article/view/6026

How to Cite

1.
Nurprilinda M, Simanjuntak EGM. Description of Leukocytes in Patients who are Positive for COVID-19 Infection. J. Drug Delivery Ther. [Internet]. 2023 Nov. 15 [cited 2025 Feb. 13];13(11):127-35. Available from: https://jddtonline.info/index.php/jddt/article/view/6026